Skip to content

Yoga on Arrhythmia Burden and Quality of Life in Paroxysmal Atrial Fibrillation

The Effect of Yoga on Arrhythmia Burden and Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00798356
Enrollment
84
Registered
2008-11-26
Start date
2008-11-30
Completion date
2012-01-31
Last updated
2012-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial fibrillation, yoga

Brief summary

Studies in the past have shown that yoga could relieve stress which is the most common trigger for recurrent episodes of atrial fibrillation. Breathing exercises in yoga are found to influence the autonomic nervous system (particularly parasympathetic) and thus reduce palpitations. This study hypothesizes that patients with atrial fibrillation might benefit by practicing yoga. Yoga may also help to better control heart rate and rhythm when used in combination with usual medical management.

Interventions

Yoga training for 12 weeks

Sponsors

Dhanunjaya Lakkireddy, MD, FACC
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with paroxysmal atrial fibrillation ages 25-80

Exclusion criteria

* Advanced malignancy or severe co-morbid conditions such as severe heart failure and with life expectancy less than 1 year * Pregnant women * Unmedicated or uncontrolled high blood pressure * A past history of pneumothorax * Severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse * Carotid stenosis * History of psychosis or substance abuse * History of epilepsy * Glaucoma * History of total hip replacement * Ablation within 3 months of the start date of study * Patients who have not seen a cardiovascular physician in the last year

Design outcomes

Primary

MeasureTime frame
frequency and duration of atrial fibrillation episodes12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026